Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06333899 |
| Title | Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Nationwide Children's Hospital |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | NLD | DEU | CAN | AUS |
CKB BOOST